AI-generated summary
The authors report a small pilot, double-blind, placebo-controlled trial in dementia patients that tested 28 six-minute transcranial sessions of near infrared light at 1060 to 1080 nm. They report changes in several executive and memory measures, along with a trend toward improved EEG measures. The sample was very small, with only 6 active and 3 control participants analyzed.
- Participants
- 11
- Who or what was studied
- Patients independently diagnosed with dementia, recruited from an outpatient behavioral healthcare clinic
- Wavelengths
- 1060, 1080 nm
- Limits stated in the abstract
- The trial was a small pilot with only 6 active and 3 control participants, and 2 dropouts, so the findings are preliminary.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on jneuro.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 600-1000 nm, 1060-1080 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Dementia, Photobiomodulation, Near-infrared, Statistical significance, Electroencephalography, Placebo-controlled, Neuroplasticity. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.